These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 2466942
1. Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes. Kuwano K, Scott M, Young JF, Ennis FA. J Exp Med; 1989 Apr 01; 169(4):1361-71. PubMed ID: 2466942 [Abstract] [Full Text] [Related]
2. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. Kuwano K, Scott M, Young JF, Ennis FA. J Immunol; 1988 Feb 15; 140(4):1264-8. PubMed ID: 2449498 [Abstract] [Full Text] [Related]
3. Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Kuwano K, Braciale TJ, Ennis FA. Viral Immunol; 1989 Feb 15; 2(3):163-73. PubMed ID: 2483503 [Abstract] [Full Text] [Related]
4. Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. Yamada A, Ziese MR, Young JF, Yamada YK, Ennis FA. J Exp Med; 1985 Aug 01; 162(2):663-74. PubMed ID: 3160807 [Abstract] [Full Text] [Related]
5. Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone. Kuwano K, Reyes VE, Humphreys RE, Ennis FA. Mol Immunol; 1991 Aug 01; 28(1-2):1-7. PubMed ID: 1707132 [Abstract] [Full Text] [Related]
6. Cross-reactive protection against influenza A virus infections by an NS1-specific CTL clone. Kuwano K, Tamura M, Ennis FA. Virology; 1990 Sep 01; 178(1):174-9. PubMed ID: 1697125 [Abstract] [Full Text] [Related]
9. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72. Saikh KU, Martin JD, Nishikawa AH, Dillon SB. Virology; 1995 Dec 20; 214(2):445-52. PubMed ID: 8553546 [Abstract] [Full Text] [Related]
10. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. Fries LF, Dillon SB, Hildreth JE, Karron RA, Funkhouser AW, Friedman CJ, Jones CS, Culleton VG, Clements ML. J Infect Dis; 1993 Mar 20; 167(3):593-601. PubMed ID: 8440931 [Abstract] [Full Text] [Related]
11. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin. Wabuke-Bunoti MA, Taku A, Fan DP, Kent S, Webster RG. J Immunol; 1984 Oct 20; 133(4):2194-201. PubMed ID: 6206156 [Abstract] [Full Text] [Related]
12. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Mbawuike IN, Dillion SB, Demuth SG, Jones CS, Cate TR, Couch RB. Vaccine; 1994 Nov 20; 12(14):1340-8. PubMed ID: 7856302 [Abstract] [Full Text] [Related]
13. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design. Liu WC, Jan JT, Huang YJ, Chen TH, Wu SC. J Virol; 2016 Oct 01; 90(19):8496-508. PubMed ID: 27440889 [Abstract] [Full Text] [Related]